What is the current valuation of the UK Interventional Cardiology Market?

As of 2024, the market valuation was 1.22 USD Billion. Read More

What is the projected market size for the UK Interventional Cardiology Market by 2035?

The market is projected to reach 2.03 USD Billion by 2035. Read More

What is the expected CAGR for the UK Interventional Cardiology Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 4.69%. Read More

Which segments are included in the UK Interventional Cardiology Market?

The market includes segments such as Coronary Angioplasty, Peripheral Angioplasty, and Structural Heart Procedures. Read More

What are the key players in the UK Interventional Cardiology Market?

Key players include Boston Scientific, Medtronic, and Abbott Laboratories. Read More

How does the market perform in terms of device types?

By device type, the market includes Balloon Catheters, Stents, and Ablation Devices, with Stents valued at 0.45 to 0.75 USD Billion. Read More

What is the valuation of the Peripheral Angioplasty segment?

The Peripheral Angioplasty segment was valued between 0.25 and 0.4 USD Billion. Read More

What is the significance of hospitals as an end user in the market?

Hospitals are projected to account for a market valuation between 0.55 and 0.9 USD Billion. Read More

What procedure types are included in the UK Interventional Cardiology Market?

Procedure types include Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement. Read More

What is the expected growth trend for the Structural Heart Procedures segment?

The Structural Heart Procedures segment is projected to grow from 0.2 to 0.35 USD Billion by 2035. Read More

UK Interventional Cardiology Market

ID: MRFR/HC/49431-HCR

200 Pages

Vikita Thakur

Last Updated: May 12, 2026

UK Interventional Cardiology Market Research Report: By Product Type (Coronary Stents, Balloon Catheters, Guidewires, IVUS Catheters, Other Devices), By Procedure Type (Coronary Angioplasty, Coronary Bypass Surgery, Peripheral Angioplasty, Transcatheter Aortic Valve Replacement), By End User (Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers) and By Distribution Channel (Direct Sales, Distributors, Online Sales) - Forecast to 2035

UK Interventional Cardiology Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 UK Interventional Cardiology Market, BY Application (USD Billion) | |
  1. 4.1.1 Coronary Angioplasty | |
  2. 4.1.2 Peripheral Angioplasty | |
  3. 4.1.3 Structural Heart Procedures | |
  4. 4.1.4 Electrophysiology | |
  5. 4.1.5 Valvular Interventions |
2. 4.2 UK Interventional Cardiology Market, BY Device Type (USD Billion) | |
  1. 4.2.1 Balloon Catheters | |
  2. 4.2.2 Stents | |
  3. 4.2.3 Guidewires | |
  4. 4.2.4 Ablation Devices | |
  5. 4.2.5 Access Devices |
3. 4.3 UK Interventional Cardiology Market, BY Procedure Type (USD Billion) | |
  1. 4.3.1 Percutaneous Coronary Intervention | |
  2. 4.3.2 Transcatheter Aortic Valve Replacement | |
  3. 4.3.3 Coronary Artery Bypass Grafting | |
  4. 4.3.4 Atrial Septal Defect Closure | |
  5. 4.3.5 Left Atrial Appendage Closure |
4. 4.4 UK Interventional Cardiology Market, BY End User (USD Billion) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Cardiac Catheterization Labs | |
  3. 4.4.3 Ambulatory Surgical Centers | |
  4. 4.4.4 Research Institutions 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the UK Interventional Cardiology Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the UK Interventional Cardiology Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Abbott Laboratories (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Johnson & Johnson (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 B. Braun Melsungen AG (DE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Terumo Corporation (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Cardinal Health (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Siemens Healthineers (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Philips (NL) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 UK MARKET ANALYSIS BY APPLICATION |
6. 6.3 UK MARKET ANALYSIS BY DEVICE TYPE |
7. 6.4 UK MARKET ANALYSIS BY PROCEDURE TYPE |
8. 6.5 UK MARKET ANALYSIS BY END USER |
9. 6.6 KEY BUYING CRITERIA OF UK INTERVENTIONAL CARDIOLOGY MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF UK INTERVENTIONAL CARDIOLOGY MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: UK INTERVENTIONAL CARDIOLOGY MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: UK INTERVENTIONAL CARDIOLOGY MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: UK INTERVENTIONAL CARDIOLOGY MARKET |
15. 6.12 UK INTERVENTIONAL CARDIOLOGY MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 UK INTERVENTIONAL CARDIOLOGY MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion) |
17. 6.14 UK INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2024 (% SHARE) |
18. 6.15 UK INTERVENTIONAL CARDIOLOGY MARKET, BY DEVICE TYPE, 2024 TO 2035 (USD Billion) |
19. 6.16 UK INTERVENTIONAL CARDIOLOGY MARKET, BY PROCEDURE TYPE, 2024 (% SHARE) |
20. 6.17 UK INTERVENTIONAL CARDIOLOGY MARKET, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion) |
21. 6.18 UK INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2024 (% SHARE) |
22. 6.19 UK INTERVENTIONAL CARDIOLOGY MARKET, BY END USER, 2024 TO 2035 (USD Billion) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
  2. 7.2.2 BY DEVICE TYPE, 2026-2035 (USD Billion) | |
  3. 7.2.3 BY PROCEDURE TYPE, 2026-2035 (USD Billion) | |
  4. 7.2.4 BY END USER, 2026-2035 (USD Billion) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

UK Interventional Cardiology Market Segmentation

UK Interventional Cardiology Market By Application (USD Billion, 2022-2035)

Coronary Angioplasty
Peripheral Angioplasty
Structural Heart Procedures
Electrophysiology
Valvular Interventions

UK Interventional Cardiology Market By Device Type (USD Billion, 2022-2035)

Balloon Catheters
Stents
Guidewires
Ablation Devices
Access Devices

UK Interventional Cardiology Market By Procedure Type (USD Billion, 2022-2035)

Percutaneous Coronary Intervention
Transcatheter Aortic Valve Replacement
Coronary Artery Bypass Grafting
Atrial Septal Defect Closure
Left Atrial Appendage Closure

UK Interventional Cardiology Market By End User (USD Billion, 2022-2035)

Hospitals
Cardiac Catheterization Labs
Ambulatory Surgical Centers
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓